Senior Director, Access Strategy & Marketing at Revolution Medicines | USA | $232K/yr – $290K/yr

Senior Director, Access Strategy & Marketing

USA (Remote)

$232K/yr – $290K/yrSenior LevelFull time

Posted 3 months ago

Job Summary

Own cross functional access strategy for a NSCLC portfolio, coach the Market Access team, and drive launch readiness, with a sharp focus on payer value messaging and compliant collaboration with Medical Affairs and Brand/Regulatory.

Access Strategy & Launch Readiness: Align with stakeholders on a three year plan and oversee senior level forums.
Team Leadership & Stakeholder Alignment: Build an Access Marketing team and coordinate with national accounts and payers.
Evidence & Compliance Collaboration: Shape data strategy and ensure materials meet regulatory guidelines while supporting brand goals.

Job Description

Responsibilities

Develop and align with cross-functional partners on the three-year access strategy across RevMed’s NSCLC portfolio.
Lead and coach team of Access Marketers.
Coordinate launch readiness efforts across Market Access team and represent Market Access in senior-level forums (i.e., cross-functional launch planning, labelling team, etc).
Lead the creation of value proposition messaging and materials tailored for payers, PBMs, IDNs, GPOs, channel partners, and other key managed care decision-makers.
Develop strong relationship with Medical Affairs to inform data strategy and evidence generation plan.
Partner with national account field team to inform strategy and materials development.
Work closely with Brand Marketing, Regulatory and Compliance to ensure all materials support brand goals and follow compliance guidelines.

Revolution Medicines

3.5 Glassdoor

We are Revolutionaries – passionate in our singular pursuit of discovering, developing and delivering innovative, targeted medicines for patients living with cancer. To deliver on our vision, we work relentlessly in pursuit of cutting-edge therapeutic approaches to some of the toughest cancers. Our current focus is on RAS-addicted cancers, which account for 30 percent of all new human cancer diagnoses.

Founded in 2014

Redwood City, California, USA

817 employees (26 in marketing)

www.revmed.com

54% recommend to a friend

64% CEO approval